v3 Template
V

Vaxcyte, Inc.

Biotechnology / Healthcare San Carlos, California, United States ~460 employees
Founded
--
Employees (Est.)
~460
23 leaders known
Total Funding
$8.2B
Funding Rounds
10
Last Funding
2026-02-02

About Vaxcyte, Inc.

Vaxcyte is dedicated to eliminating bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella, aiming to protect children and adults globally through innovative vaccine development.

Products & Services

VAX-31:A 31-valent pneumococcal conjugate vaccine (PCV) being studied for the prevention of invasive pneumococcal disease (IPD), designed to elicit strong immune responses.
Group A Strep Vaccine Candidate:An early-stage vaccine candidate targeting Group A Strep infections.

Specialties

Pneumococcal Conjugate Vaccines (PCVs) Cell-Free Protein Synthesis Platform Broad-Spectrum Vaccine Development Bacterial Infection Prevention

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering 		A: 632500000
MR: -
FA: 632.5 million
FAN: 632500000 		D: 2026-02-02
FD: 2026-02-02 		8 investors
2 RT: Public Offering
T: -
FT: Public Offering 		A: 500000000
MR: -
FA: $500,000,000
FAN: 500000000 		D: 2026-01-29
FD: 2026-01-29 		5 investors
3 RT: Public Offering
T: -
FT: Public Offering 		A: 550000000
MR: -
FA: 550 million
FAN: 550000000 		D: 2026-01-29
FD: 2026-01-29 		8 investors
4 RT: Public Offering
T: -
FT: Public Offering 		A: 1500000000
MR: -
FA: 1.5 billion
FAN: 1500000000 		D: 2024-09-06
FD: 2024-09-06 		7 investors
5 RT: Public Offering
T: -
FT: Public Offering 		A: 1300000000
MR: -
FA: approximately $1.3 billion
FAN: 1300000000 		D: 2024-09-04
FD: 2024-09-04 		7 investors
6 RT: Public Offering
T: -
FT: Public Offering 		A: 1000000000
MR: -
FA: 1.0 billion
FAN: 1000000000 		D: 2024-09-03
FD: 2024-09-03 		7 investors
7 RT: Public Offering
T: -
FT: Public Offering 		A: 862500000
MR: -
FA: 862.5 million
FAN: 862500000 		D: 2024-02-02
FD: 2024-02-02 		8 investors
8 RT: Public Offering
T: -
FT: Public Offering 		A: 750000000
MR: -
FA: 750 million
FAN: 750000000 		D: 2024-01-30
FD: 2024-01-30 		8 investors
9 RT: Public Offering
T: -
FT: Public Offering 		A: 575000000
MR: -
FA: 575 million
FAN: 575000000 		D: 2023-04-21
FD: 2023-04-21 		8 investors
10 RT: Public Offering
T: -
FT: Public Offering 		A: 500000000
MR: -
FA: approximately $500 million
FAN: 500000000 		D: 2023-04-19
FD: 2023-04-19 		8 investors
Public Offering Latest
2026-02-02
$632.5M
8 investors (Pro only)
Public Offering 2026-01-29
$500.0M
Public Offering 2026-01-29
$550.0M

View 9 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

G

Grant Pickering

Chief Executive Officer, Director and Co-Founder

LinkedIn (Pro only)
A

Andrew Guggenhime

President and Chief Financial Officer

LinkedIn (Pro only)
J

Jim Wassil

Executive Vice President and Chief Operating Officer

LinkedIn (Pro only)
H

Harp Dhaliwal

Chief Technical Operations Officer

W

Whitney Jones

Chief People Officer

M

Mikhail Eydelman

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Vaxcyte, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~460 employees (est.)
Locations
San Carlos, California, United States

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro